This guidance also signposts readers to some of the great work that has already been done in this field.
However, high quality polypharmacy prescribing data particularly measured over time used in combination with data showing hospital admissions or harm to people caused by taking medicines could be utilised in combination to identify where initiatives to address polypharmacy have been successful or not and how they could be improved.
This review states that mitigation of these factors requires a person-centred approach to stopping medicines with a structured process which includes planned medication reduction and withdrawal with appropriate follow up and monitoring.
These were Scotland, Germany and the Netherlands Canada Polypharmacy.
Furthermore, for every one more pill prescribed, the prescribed pill was less detectable in their blood, showing reduced compliance.
Data sources should be shared within a health economy and should prompt discussions and questions.